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INTRODUCTION 
 
 The amniotic fluid and the chorioamnion which form the bag of 
membranes aids in accomplishing the safe journey of the foetus.  The 
amnion at term is a tough, tenacious and pliable membrane which is 
avascular and derived from the ectoderm. Amniotic fluid arises from both 
maternal and foetal side which is replaced every 3 hours.  At term it 
measures around 600-800 ml.  It functions as a shock absorber, maintains 
even temperature and allows free movement of the foetus.  The 
chorioamnion acts as a barrier for the pathogens present in the vagina.  
Spontaneous rupture of membrane most often occurs  during the course 
of active labour. 
 
1. Premature rupture of membrane (PROM) is defined as spontaneous 
rupture of the chorioamnion before the onset of uterine contraction. 
2. Rupture of membrane after 37 completed weeks is PROM 
3. Rupture of membrane before 37 weeks is preterm PROM 
4. The incidence of PROM is 4-18% at term. Infection  closely 
associates either as an aetiological factor or an important sequence 
of PROM. 
Management of PROM at term remains controversial. Management 
of PROM, not in labour is best managed by individualized approach.  The 
different modes of management are either expectant management or 
induction of labour.  The standard practice for dealing with PROM at 37 
weeks or more has been to induce labour within 6-12 hours after the 
rupture of membranes if the patient is not in labour  .  The rationale for 
this approach is to prevent   chorioamnionitis that is  associated with high 
maternal & perinatal morbidity and mortality. 
 
 Newborn at term has increased chances of sepsis and increased need 
for neonatal resuscitation at delivery. 
Induction of labour in PROM, not in labour has advantage over 
expectant management. 
In this study we compared the safety & efficacy of prostaglandin  E2 
Gel administered in endocervical canal with that of intravenous oxytocin 
infusion for labour induction in  PROM. 
 
 
 
 
  
 
                              
AIM OF THE STUDY 
 
1. To compare that efficacy and safety  of  Prostaglandin E2 gel 
with intravenous oxytocin for induction of labour in prelabour 
rupture of membrane.  
 
2. To compare the mode of delivery and induction to delivery 
interval between   both groups. 
 
3. To compare the neonatal outcome and immediate puerperal 
problems between both groups.  
 
 
 
 
REVIEW OF LITERATURE 
1. A study conducted by Goeshchen K et al in Department of O.G. 
Germany, in term PROM patients for induction of labour with 
endocervical ceviprime gel 0.5mg Vs. intravenous oxytocin infusion was 
made.  The clinical outcome of labour, interval between the PROM to 
delivery, the incidence of operative delivery and neonatal outcome were 
compared.  579 women in this study group were divided into two groups.  
The clinical outcome was significantly better in the PGE2 treated 
patients.  No adverse effects on the neonate was observed. 
 
2. A study conducted by Mahmood TA, in Department of OG, UK 
which compared the conservative line of management Vs intravaginal 
PGE2 gel in term PROM cases and studied the main outcome of PROM 
to delivery, Oxytocin augmentation, mode of delivery, maternal and 
neonatal infective morbidity.  There is significant reduction in the PROM 
to delivery interval in women managed actively with PGE2 gel and fewer 
women required oxytocin augmentation. (31% Vs 51%).  No significant 
difference was noted in the infective morbidity and caesarean section 
rate. 
3. A study conducted by Tan BP, Hannah ME, compared 
prostaglandin Vs Oxytocin for PROM cases at term.  Early stimulation of 
uterine contraction with prostaglandin with or without oxytocin Vs.  
Oxytocin alone was made.  Eight trials were included.  Based on three 
trials, prostaglandin compared to oxytocin were associated with increased 
risk of chorioamnionitis and neonatal infection. Based on four trials, 
prostaglandin were associated with decreased need for epidural analgesia.  
Caesarean section rate, endomertritis and perinatal mortality were not 
significant in both groups. 
 
4.  In Meikel et al study, conducted in Department of O&G, Denvar, in 
patients with term PROM, the rate of endometritis, clinical 
chorioamnionitis, caesarean delivery, neonatal sepsis were analysed.   
The caesarean rate was 12%, Chorioamnionitis 6.8%. Neonatal 
complications were limited to only 2 cases.  The neonatal sepsis occurred 
in patients with rupture of membranes for more than 24 hours.  They 
concluded higher rate of vaginal delivery and low rate of maternal and 
neonatal complication, from their study. 
 
 
5.   The study conducted in the Department of OG, Ramathibodi 
hospital, Thailand, by Herabutya et al, compared intravenous oxytocin 
with or without 3mg intravaginal PGE2 in term PROM cases.  There was 
no statistically significant difference between the two treatment groups in 
induction to delivery interval. 
 
6.  Arulkumaran et al, conducted a randomized comparison of vaginal 
prostaglandin gel vs oxytocin infusion for stimulation of labour at term 
for PROM.  The trial showed reduced requirement of epidural analgesia, 
increased incidence of chorioammionitis with vaginal prostaglandin (Tan 
& Hannah 2000).  The perinatal morbidity and mortality and caesarean 
section rate were similar.  In a women the term PROM, PGE2 and 
oxytocin were equally effective for induction of labour. 
 
7. A study conducted in Department of OG in NRS college, Kolkatta 
by Chaudhuri Snahamay et al, which compared the immediate induction 
with 0.5mg intravaginal PGE2 gel and delayed induction with IV 
oxytocin in term PROM cases.  Mode of delivery, labour characteristics 
and neonatal and maternal morbidity were compared between both 
groups.  91% required single application of gel. Immediate induction  
with intravaginal PGE2 gel resulted in significantly lower caesarean 
section rate, (17.8% Vs 28.5%), Low operative vaginal delivery (3.5 Vs 
14.2%) in nullipara compared to oxytocin.  No significant difference 
noted in multi para.  There is no significant difference in neonatal 
infection rate in both groups. (2.7 Vs 3.5%). 
 
8. A study conducted by Ekman et al, compared oxytocin with PGE2 
gel in cases of PROM with unripe cervix. Cervical priming and labour 
induction in 20 nulliparus term pregnant women with premature rupture 
of membranes and unfavourable cervical state was done with intravenous 
oxytocin for 10 cases and PGE2 gel 4 mg intravaginally for 10 cases.  
One of the ten women who received oxytocin had a favourable cervical 
state within 5 hrs, and vaginal delivery within 24 hrs compared to six of 
the ten women after PGE2 gel application, which was statistically 
significant.  Number of caesarean section was 4 and vaccum delivery was 
5 in oxytocin group compared to only 2 vaccum deliveries in cerviprime 
gel group. They concluded that PGE2 gel was superior to oxytocin for 
labour induction term PROM. 
 
  
 Premature rupture of membranes is perhaps one of the 
commonest indication for induction of labour.  
 
Incidence: 
 Varies from 2.7 to 17% (Lebherz  et al 1969, Akthar et al 1980, 
Singh et al 1990, Sanjal et al 1990). The reported incidence is varied 
greatly, likely reflecting population demographics, the study  type, the 
study interval, the method of diagnosis, the latency interval and the 
gestational age at which PROM is diagnosed. 
Etiology and pathogenesis:  
1. The chorioamniotic membranes possess dynamic properties 
characteristic of a viscoelastic material. It has the ability to adapt 
to deformation with recovery due to elastin. Membranes are 
stressed by internal pressure due to labour, external pressure by 
trauma or infection which weaken & increase the susceptibility 
to premature rupture of membranes (Toppozada et al)  
2. Infection: It is the major etiologic agent in the pathogenesis  of 
PROM 
Organisms responsible are: 
 Group B streptococcus 
 Bacteroids 
 Gardnerella vaginalis 
 Chlamydia, gonorrhoea 
 
             The possible mechanisms are : 
a) Activation of phospholipase A2 enzyme & subsequent increase 
in prostaglandin production which increases the uterine activity 
& adds stress on the membranes (Bejan et al 1981.) 
b) Infection leads to production of proteolytic enzymes & 
liberation of hydrogen peroxide which results in break down of 
membranes (Sharra et al 1985). 
c) Increase in the lysolecithin due to phospholipase A2 lowers the 
membrane burst pressure. 
3. A local defect at or near the cervix with reduction in type 3 
collagen predisposes to membrane rupture. 
4. Obstetric factors like multiple gestation & hydramnios 
predispose to membrane rupture. 
5. Sexual activity predisposes to PROM due to bacterial deposition 
close to the cervical os. Stimulation of uterine activity by 
orgasm or seminal prostaglandins could lead to PROM. 
(Rayburn & Wilson 1980). 
6. Low serum levels of ascorbic acid, copper, zinc have been 
associated with PROM.A strong association between smoking & 
PROM has been observed (Meyer et al 1977, Naeye et al 1982.) 
7. Invasive procedures like amniocentesis, fetoscopy, 
cordocentesis may result in PROM. 
8. Genetic disorders like Ehlers –Danlos syndrome, a connective 
tissue disorder  associated with fragile membrane & hence 
PROM. 
9. Increase in Prolactin level which changes the elastic property of 
fetal membranes via its effect on the membrane water & 
electrolyte content predisposes to PROM ( Ron et al). 
Pathology: 
 There is thinning of the epithelium at the site of rupture with 
decrease in tensile strength. Collagen sheets & fibril bundles are 
dissolved & replaced by amorphous material signifying disorientation of 
extracellular matrix. Any factor which increases the mechanical stress on 
that area certainly predisposes to early rupture.  
 
  
Significance : 
            Rupture of membranes is of significance for three reasons. 
1. If presenting part is not fixed in the pelvis the possibility of cord 
prolapse & cord compression is increased. 
2. Labour may occur shortly. 
3. If labour is delayed for >24 hours there is increased likelihood of 
serious maternal and neonatal infection. 
  
DIAGNOSIS:  
 Tools reportedly useful in diagnosis of prom 
History & examination    Sonography & dye instillation 
History       Sonography 
Observation of leak    Evans blue 
Fundal height     Sodium fluorescin 
Odour      Methylene blue 
       Indigo carmine 
       Pyridium 
 
Properties of amniotic fluid   Microscopy/ Cytologystains 
Ferning       Lanugo 
pH       litmus     Sudan III 
Bromothymol blue   Masson trichome 
Nitrazine     Papanicolaou 
Diamine oxidase      Pinacyanole 
        Acridine orange 
        Nile blue sulphate 
        Vernix cell identification 
1. Observation of aminorrhexis:  
Diagnosis is made easily when amniotic fluid is in posterior fornix.If 
no fluid is present slight pressure on the uterus and gentle movement of 
the foetus may provoke leaking. Otherwise ask the patient to cough or 
strain. Fluid should be collected over the lower blade of speculum before 
it comes in contact with the vaginal wall. 
 
2. Nitrazine Test:   
The vaginal pH is normally 4.5-5.5.  Amniotic fluid usually has a pH 
of 7-7.5. Nitrazine paper quickly will turn to deep blue if the vaginal fluid 
has an alkaline pH. The membranes probably are intact if the colour of 
the paper remains yellow or changes to olive-yellow. Antiseptic 
solutions, urine, blood & vaginal infections alter the vaginal pH and 
cause false positive results. The nitrazine test produces 12.7 % false 
negative & 16.2% false positive results. 
 
3. Ferning: 
Ferning results due to drying  out of  salts in the  amniotic fluid. The 
sample is placed on a glass slide & allowed to dry, then observed under 
the microscope looking for a crystallization pattern that resembles a fern. 
False negative ferning is due to blood or meconium (4.8%), false positive 
is (4.4%). 
4.Evaporation Test:  
For the evaporation test, Endocervical sample are heated until the 
water content has evaporated. If a white residue is left, amniotic fluid is 
present. If the residue is brown the membranes are intact.  
5.Intraamniotic fluorescein:  
 1ml of a sterile solution of 5% sodium fluorescein is injected in to 
the amniotic cavity. A tampon is placed in the vagina and examined with 
long wave ultraviolet light 1 or 2 hr later. The detection of fluorescent 
material is equivalent to a positive diagnosis of PROM. 1 ml of sterile 
indigocarmine may be used instead of fluorescein and the tampon is 
inspected for the presence of blue discoloration. 
6.Amnioscopy:  
Amnioscopy is an invasive procedure rarely indicated in the 
diagnosis / management of PROM. It requires a distensible cervix to 
introduced a metallic or plastic cone for direct visulization of the 
membrane and the amniotic fluid. Amnioscopy may cause PROM is 
patients with intact membrane and may carry a large bacterial inoculum 
in to the amniotic cavity in patients with PROM. 
7.Sonography:  
Presence of amniotic fluid rules out PROM. Amniotic fluid is 
measured by four quadrant technique. False positive results can occur in 
oligohydramnios. Occult loss may be missed as the reduction of amniotic 
fluid is less. But sonography is not used primarily for diagnosing PROM. 
Intramniotic instillation of dye is an invasive procedure which is hardly 
used due to the deleterious effect of dye, infection and  missing of 
meconium stained liquor. 
8.Fetal fibronectin: 
Fetal fibronectin is a large molecular weight glycoprotein present in 
large amounts in the amniotic fluid. This substance can be detected in the 
endocervix or vagina  of patients with PROM by means of ELISA. The 
test seems to the highly accurate and is not affected by blood. But 
meconium may interfere. 
9.Alta fetoprotein test  
AFP is present in high concentration at the amniotic fluid, but does 
not exist in the vaginal secretion or in the urine. Therefore demonstration 
of this substance in the vaginal secretion is an accurate test for diagnosis 
of PROM. A study using a rapid calorimetric monoclonal antibody AFP 
test  found a sensitivity of 98% for AFP ,77% for Nitrazine,  and 62% for 
ferning . Specificity was 100% for AFP test. The test may be unreliable at 
term because Amniotic fluid AFP decreases with gestational age. 
Maternal blood contamination affects the accuracy of the test. 
10.Diamine oxidase Test:   
It is an enzyme produced by decidua, which diffuses into the 
amniotic fluid. Measurement by a paper strips placed in vagina is an 
accurate way to diagnose PROM.  
11.Microscopic & cytological stains have limited role. 
History, nitrazine test, ferning or nile blue staining are usually used 
to evaluate the presence of membrane rupture. Positive results of any two 
tests  gives an accuracy of about 93%. 
 
 COMPLICATIONS 
 Maternal complications: 
1. Chorioamnionitis incidence is 9%.It depends on the gestational age 
of PROM, duration of latent period and amniotic fluid volume. 
Chorioamnionitis is defined by one of the following signs: 
¾ Two temperature elevations of > than 37.5oC occurring at least 1 
hour apart or One temperature elevation of >  than 38oC 
¾ Uterine tenderness 
¾ Foetal tachycardia (180/min) 
¾ WBC count >20000 /cu.mm 
¾ Foul smelling amniotic fluid 
2.Postpartum endometritis is defined by any one of the following: Fever 
after delivery (2 temperature elevations >38C occurring at least 6 hours 
apart not including the first 24 hours)  
• Uterine tenderness  
• WBC count  > 20,000 / cu.mm 
• Unhealthy lochia                                                                        
                                                                                                                                     
 
  
3.Abruptio placenta:  
Incidence is 6%. It is due to progressive decrease in the intrauterine 
surface area causing detachment. 
 
Foetal Complications 
 Depends on the gestational age at which PROM occurs 
1. Neonatal sepsis: Incidence increases to 1.4% due to PROM. 
2. All complications of prematurity in preterm PROM. 
3. Lung hypoplasia 
4. Foetal deformities 
5. During labour chances of cord prolapse, foetal distress is more 
 
 
 
 
 
 
 
MANAGEMENT 
After confirming PROM, and gestational age patients who require 
immediate delivery should be identified. They are: 
1. In Labour 
2. At Term 
4. With foetal distress 
5. With congenital anamolies 
6. Chorioamnionitis 
7. Those who are at high risk for infection like diabetes, heart 
disease, on immunosuppresants, sickle cell disease. 
 
Management of patients at term or near term  
 This is controversial, expectant vs. active management. At term 
90% of patients will go into spontaneous labour at the end of 24hrs.  38% 
of patients were not in labour even at the end of 24hrs which increases 
likelihood of infection to 10%. Studies have shown that active 
management is cost effective & gives better patient satisfaction.  
 According to ACOG practice guidelines June 1998 (Level A) 
Patients who come with term PROM, labour may be induced at the time 
of presentation or may be observed for 24-72 hours for onset of 
spontaneous labour. Digital examination should not be performed in 
whom immediate induction is not planned. 
Management of patients with gestational age<32 weeks 
 Management of these patients is a compromise between 
maternal infection & pre maturity of the fetus. Expectant management     
is the mode of treatment.                                                                                                  
(According to ACOG practice bulletin (June 1998) 
 Antibiotics improve the perinatal outcome by reducing the 
chances of infection. Antenatal steroids are to be administered to reduce 
the risk of RDS, intra ventricular haemorrhage, necrotising entercolitis, 
neonatal death. Tocolysis to permit administration of steroids and 
antibiotics.  Digital examination should not be done. Terminate the 
pregnancy if there are signs of chorioamnionitis. 
Management of PROM in gestational age <26 weeks  
 This group of patients have a very poor perinatal outcome. 48% 
will deliver within 3  days, 67% with in 1 week, 83% with in 2 weeks. 
Perinatal mortality is 60-90%. 50% will develop chorioamniotitis, 6.8% 
will have an abruption & 50% will be delivered by cesarean section. 16% 
of the surviving newborns will have long term sequelae. If the latency is 
> 4 weeks there is high risk for fetal musculoskeletal deformities & 
pulmonary hypoplasia. No plan of management has shown to improve the 
neonatal outcome.  
INDUCTION OF LABOUR 
Definition: 
 Artificial stimulation of uterine contractions before the onset of 
spontaneous labour with the purpose of accomplishing successful  
vaginal delivery. Augmentation means enhancing uterine contractions 
once labour has started. For successful induction cervical ripening is 
important. 
Physiology of cervical ripening: 
Progressive increase in gestation or vaginal infection 
Increase in cervical hyaluronidase & decreased collagenase 
inhibitors.Down regulation of estrogen & progesterone receptors. 
 
Increased Interleukin 8 & Interleukin 1 β 
Stimulates collagenase & neutrophilic chemotaxis 
Enzymatic degradation of extracellular matrix 
Increased water content 
Decreased collagen concentration & structural rearrangement 
Alteration of proteoglycans & glycosaminoglycans ratio 
 
CERVICAL RIPENING 
INDICATION FOR INDUCTION OF LABOUR 
Maternal indications: 
• Abruptio placenta 
• PROM 
• Chorioamnionitis 
• Post term 
• PIH, pre eclampsia, eclampsia 
• Maternal conditions like diabetes, renal disorder, chronic hypertension 
Fetal indications: 
• Fetal demise 
• Fetal malformation incompatiable with life 
• Fetal jeopardy like IUGR 
CONTRAINDICATIONS FOR INDUCTION OF LABOUR 
Absolute: 
• Severe CPD 
• Placenta previa III&IV 
• Transverse lie 
• Previous classical caesarean or myomectomy 
• Active genital herpes infection 
• Invasive cervical carcinoma 
• Pelvic structural deformities. 
Relative; 
• Grand multipara 
• Previous LSCS 
• Multiple pregnancy 
• Breech 
• Poly hydramnios 
• Presenting part above inlet 
• Maternal heart disease 
 
Pre requisites for induction: 
• Establish the indication 
• Informed consent 
• Pelvic assessment 
• Confirmation of gestational age 
• Assessment of fetal size & presentation 
• Cervical assessment ( modified Bishop score) 
 
 
 
 
BISHOP SCORE – In 1964 E.H. Bishop suggested a qualitative pelvic 
scoring based on 500 pelvic examinations for success of induction. 
Factors 0 1 2 3 
Cervical Dilatation  (cm) Closed 1-2 3-4 5+ 
Effacement of cervix (%) 0-30 40-50 60-70 80+ 
Consistency of cervix Firm Medium Soft  
Position of cervix Posterior Mid line Anterior  
Head station  -3 -2 -1,0 +1,+2 
 
Unfavorable score <6 
Favorable score 6,>6 
METHODS OF INDUCTION 
• Natural methods 
• Mechanical methods  
• Pharmacological methods  
 
Natural methods: 
• Nipple stimulation 
• Sexual intercourse 
• Enema 
Mechanical methods: 
• Stripping of membranes 
• Balloon catheters 
• Lamanaria tents 
• Synthetic osmotic dilators 
• Amniotomy also known as surgical induction, used for induction & 
augmentation.  
Pharmacological methods;  
Drugs commonly used are: 
• Oxytocin 
• Prostaglandins 
OXYTOCIN 
 Oxytocin is secreted by the posterior pituitary along with ADH. 
It is an octapeptide and simulates natural labour. Its half life is 2-7 
minutes. It is rapidly degraded in the liver & kidney by oxytocinase. 
Oxytocin binds to oxytocin receptors & increases calcium release from 
endoplasmic reticulum which increases production of prostaglandin from 
deciduas to bring about uterine contractions. Oxytocin is responsible for 
labour contractions through estrogen sensitized receptors and milk 
ejection reflex for lactation. Oxytocin was the first polypeptide hormone 
synthesized in 1953 by Du Vigneaud. 
Mode of administration: 
 Oxytocin is administered as an infusion via infusion pump or by 
manual counting in isotonic electrolyte solution .A Steady state plasma 
levels   is achieved by 30-40 minutes. 
Uses: 
• Induction of labour 
• Uterine inertia 
• Oxytocin challenge test 
• Postpartum haemorrhage 
 
 
Dosage protocols for induction: 
Regimen Starting Increment Interval Max 
(mU/min) Dose (mU/min) dose(mu/min) Min Dose(mU/min)
Low dose 0.5-1 1 30-40 20 
 1-2 2 15 40 
High dose 6 6,3,1 15-40 42 
 
                                                                                                                
Side effects : 
• Hyper stimulation –In high dose protocol 
• Failed induction 
• Uterine rupture 
• Hypotension –IV bolus 
• Water intoxication 
• Neonatal hyper bilirubinemia 
 
RCOG GUIDELINES: 
¾ Oxytocin should be started 4-6 hours following prostaglandins 
¾ In women with intact membrane, do an amniotomy & then start 
oxytocin  
¾ Minimum possible dose should be used & titrated against 
uterine contractions.  
¾ Maximum licensed dose is 20mU/min & should not exceed 
32mU/min. 
 
 
 
PROSTAGLANDINS : 
 First described by Von Euler and is believed to originate from 
prostate and seminal vesicle. 
 They are biologically active derivatives of 20 carbon atom poly 
unsaturated essential fatty acids that are synthesised from the cell 
membrane.  Prostaglandins are derivatives of prostanoic acid.  They are 
metabolized in the liver and excreted through the kidneys.  
Prostaglandins have varied actions depending upon the tissue and type of 
prostaglandin.  The probable mechanism of action  is alteration of 
membrane bound Ca++ by inhibiting adenyl cyclase and decreasing the 
level of intracellular cyclic AMP. 
The physiological roles of prostaglandins in female reproductive tract are 
Ovulation, Sperm transport, Luteolysis, Menstruation, Labour. 
Modes of administration:  
 Intra muscular 
 Intravenous (not used now) 
 Oral 
 Vaginal 
 Rectal 
        Sublingual 
 
 
Uses : 
 Medical abortion 
 Cervical ripening before surgical abortion 
 Induction of labour in second trimester 
 Cervical priming and induction of labour in third trimester 
 In prevention and treatment of post partum haemorrhage 
Other Uses : 
 Peptic ulcer 
 To maintain patency of ductus arteriosus 
          In glaucoma as second line of drugs 
Contraindications : 
 Absolute : 
  Hypersensitivity 
  Asthma 
  Uterine scar 
 Relative 
  Hypertension 
  CVS disease 
  Renal disease 
  Liver disease 
  Glaucoma 
Side effects : 
 Fever 
 Nausea, vomiting 
 Diarrhoea 
 Bronchospasm 
 Uterine hyper stimulation 
Commonly used prostaglandins are 
 Prostaglandin E1 (Misoprostol) 
 Prostaglandin E2 (Cerviprime gel) 
 Prostaglandin F2 Alpha                                                                                       
CERVIPRIME GEL : 
¾ It is a prostaglandin E2 analogue 
¾ Local application of cerviprime gel used for cervical ripening    
(ACOG) 
¾ It can be used both intra vaginally and intra cervically. 
¾ Available as 0.5 mg gel. 
¾ Most effective when vaginal pH > 4.5 
¾ Requires refrigeration  
¾ Application should be done in or near the labour ward where 
uterine activity and fetal heart rate monitoring can be performed. 
¾ Contraction occurs within first 4 hours of application and shows 
peak activity in the first 4 hours. 
¾ If oxytocin was used  for acceleration it should be started after       
 6 – 12 hrs of the after application. 
 
ACOG recommendations for induction of labour: 
Level A  :  (based on good& consistent scientific evidence) 
¾ Prostaglandin E2 (PGE2) analogues are effective agents for 
cervical ripening & labour induction . 
¾ Fetal heart rate  & uterine activity should be continuously 
monitored from the time PGE2 vaginal insertion . 
¾ High dose PGE2 vaginal suppository may be used in 2nd trimester 
fetal demise. 
¾ Misoprostol 25μg every 3-6 hrs is effective for cervical ripening & 
labour induction.  
¾ With PROM, induction may be done with prostaglandins. 
¾ Either low/high dose oxytocin regime may be used for induction. 
 
Level B (based on limited/ inconsistent scientific evidence) 
¾ Use of misoprostol is to be avoided in women with previous LSCS 
¾ Higher doses of misoprostol are associated with increased risk of 
uterine hyperstimulation.  
Level C (Based on Upon consensus & expert opinion) 
¾ Intra vaginal misoprostol for induction of labour in 3rd trimester 
with fetal demise                                                                                                     
¾ FHR & uterine activity should be monitored from 30 min to 2hours 
after prostaglandin administration in live fetus. 
 
MATERIALS AND METHODS 
 
Period of study : 
         July 2006 to July 2007 
Materials and methods : 
         A total of 100 women with premature of rupture of membrane 
(PROM) admitted in labour ward Govt.Rajaji hospital were recruited for  
the study. A detailed history was obtained and a clinical examination and  
obstetric examination was done. A speculum examination and a vaginal 
examination was performed. Gestational age was calculated using 
Naegle’s rule and confirmed clinically and by ultrasound. The ripeness of 
cervix was assessed using modified Bishop’s score. 
Inclusion criteria ; 
1. Primi/ multigravida 
2. >37 wks of gestation 
3. Cephalic presentation 
4. Singleton pregnancy 
5. Bishop’s score < 6 
6. No cephalopelvic disproportion 
7. Reassuring CTG  
 
 
Exclusion criteria : 
1. Multiple pregnancy 
2. Contraindication to  vaginal birth 
3. Previous uterine surgery 
4. Contraindication to prostaglandins 
5. Non reassuring CTG 
6. Chorioamnionitis 
7. Active labour 
8. Preterm premature rupture of membranes 
After admission  vital parameters like pulse , B.P, temperature was 
recorded. 
All patients underwent an obstetric examination to clinically 
confirm the gestational age, the lie of the foetus, presentation and the 
amount of liquor. A speculum examination and vaginal examination was 
done to confirm the leakage of liquor, colour of liquor, the ripeness of 
cervix, the presentation and to rule out CPD. 
An USG was done in all patients to assess the amount of liquor, 
placental position, gestational age.  CTG was done in all patients. 
Before starting on drugs, informed consent was obtained. All the patients 
were given intravenous   antibiotics. 
50 patients belonging to group A had PGE2   gel 0.5mg instilled 
into the endocervical canal. After 6 hours cervical score was assessed. If 
still unripe a second dose was instilled. If the cervical score was 
favourable >6 ,labour was augumented with 5units of oxytocin drip, 
which was titrated to achieve  effective uterine contractions. 
50 patients belonging to group B were started on i.v oxytocin drip 
5units in 500 ml of Ringer lactate. The drip rate was titrated to achieve 
effective uterine contractions. 
In both the groups, labour progress was monitored using a 
partogram.  The parameters monitored were  : 
       Maternal pulse rate, B.P, temperature, Cervical dilatation, station of 
head, foetal heart rate, drugs given.     
If any signs of foetal distress were noted, the patients were taken up 
for caesarean section. Maternal and foetal outcome and complications 
were analysed . 
Statistical Tools 
The information collected regarding all the selected cases were recorded 
in a Master Chart. Data analysis was done with the help of computer using 
Epidemiological Information Package (EPI 2002). 
 Using this software, frequencies, percentage, mean, standard deviation, 
x2 and  'p' values were calculated. A 'p' value less than 0.05 is taken to denote 
significant relationship.  
OBSERVATION 
  Out of 100, 50 were given cerviprime gel intracervical 
instillation, 50 were given iv oxytocin. 
 
RESULTS 
Table 1 : Age Distribution 
 
Cerviprime Gel 
group 
Oxytocin group Age in years 
No % No % 
Less than 20 - - 4 8 
20 – 24 20 40 29 58 
25 – 29 29 58 15 30 
30 & above 1 2 2 4 
Total 50 100 50 100 
Mean 24.9 23.96 
S.D 2.79 3.51 
‘p’ 0.1808 (Not significant) 
 
 40% (20/50) of  group A and 58% (29/50) of group B were in the age 
group of 20 to 24 years. 58%(29/50) of group A and 30%(15/50) of group B 
were in the age group of 25 to 29 years. 0% in group A and 8% (4/50) of group 
B were in  the age group of < 20 years.2%(1/50) of group A and 4%(2/50) of 
group B  were in the age group of > 30 years. There is no statistically 
significant difference between two groups. 
  
 
 
 
Table 2 : Parity 
 
Cerviprime Gel group Oxytocin group Parity 
No % No % 
Primi 30 60 33 66 
Multi 20 40 17 34 
Total 50 100 50 100 
’p’ 0.7382 (Not Significant) 
 
 
             60%(30/50) of group A and 66% (33/50) of group B were 
primigravidas . 40%(20/50) of group A  and 33%(17/50) of group B were 
multigravidas.There is no statistically significant difference between two 
groups. 
 
 
 
 
 
 
 
 
 
  
Table 3 : PROM to induction interval 
 
Cerviprime Gel group Oxytocin group PROM to 
induction 
interval in 
minutes 
No % No % 
< 120 16 32 12 24 
121 – 240 27 54 27 54 
241 – 360 6 12 11 22 
> 360 1 2 - - 
Total 50 100 50 100 
Mean 175.8 176.3 
S.D 80.05 77.9 
‘p’ 0.7717 (Not Significant) 
 
 The duration of PROM to induction was <2hours in 32% (16/50) of 
group A and  24% (12/50) of group B .         
        The duration of PROM to induction was between 2 to 4hours in 54% 
(27/50) of  both groups. 
The duration of  PROM to induction was 4 to 6 hours in 12% (6/50) of group 
A and  22%(11/50) of group B.The duration of PROM to induction was > 6 
hours in 2%        (1/ 50)of group A and 0%  in group B.There is no statistically 
significant difference between two groups. 
 
 
 
  
 
 
Table 4 : Bishop Score 
 
Cerviprime Gel group Oxytocin group Bishop Score 
No % No % 
3 25 50 10 20 
4 19 38 33 66 
5 6 12 7 14 
6 - - - - 
 
 
 The Bishop’s score was 3 in 50 %(25/50) of group A and 20% (10/50) 
of  group B.  The Bishop’s score was 4 in 38% (19/50) of group A and 
66%(33/50) of group B. The Bishop’s score was 5 in 12%(6/50) of group A 
and 14% (7/50) of group B.  
. 
 
 
 
 
 
 
 
 
 
  
 
Table 5 : PROM  to Delivery interval    
 
Cerviprime Gel 
group 
Oxytocin group PROM to 
Delivery interval 
( in minutes) Mean SD Mean SD 
 
‘p’ 
Primi 602.3 118.9 682.4 91.7 0.0104 
(Significant)
Multi 539.5 119.8 655 102.6 0.0048  
(Significant)
Total 577.2 122 673.1 95.4 0.0002 
(Significant)
 
 
The mean duration of PROM to delivery in primigravidas were 602.3 
minutes in group A and 682.4 minutes in group B. The mean duration of  
PROM to delivery in multigravidas were 539.5minutes in group A and 655 
minutes  in group B.      ‘p’ value was significant in both groups. 
 
 
 
 
 
 
 
Table 6 : Induction to Delivery interval 
  
Cerviprime Gel 
group 
Oxytocin group Induction to 
delivery interval 
(in minutes) 
 
Mean SD Mean SD 
 
 
‘p’ 
Primi 430.5 114.9 507.6 75.5 0.0034  
(Significant)
Multi 357.8 99.3 475.9 69.3 0.0004  
(Significant)
Total 401.4 113.7 496.8 74.3 0.0001 
(Significant)
 
 
The mean duration of induction to delivery in primigravidas were 430.5 
minutes in group A and 507.6minutes in group B.The mean duration of 
induction to delivery in multigravidas were 357.8 in group A and 475.9 in 
group B. ‘p’ value (0.0001) was significant in both groups. 
 
SECOND GEL REQUIRED  : 
 6% of the patient in cerviprime gel group required second gel  which 
was kept after 6 hours of first gel induction. The efficacy of single dose gel 
was 94%. 
Oxytocin acceleration in cerviprime gel induction group 
 16% of the patients in cerviprime gel group required oxytocin for 
acceleration of labour. 
 
 
  
Table 7 : Mode of Delivery 
 
Cerviprime Gel group Oxytocin group Mode of delivery 
No % No % 
a) Vaginal 
        i) Labour natural 
       ii) Outlet 
      iii) LMC 
b) LSCS 
 
40 
7 
- 
3 
 
80 
14 
- 
6 
 
40 
7 
1 
2 
 
80 
14 
2 
4 
 
 In group A 80 %(40/50) were delivered by labour naturale,14%(7/50) 
were delivered by outlet forceps,6%(3/50) were delivered by caesarean section 
for non reassuring fetal heart rate with thick meconium. 
In group B 80%(40/50) were delivered by labour naturale,14% (7/50) were 
delivered by outlet forceps.  1 patient was delivered by low midcavity 
forceps.4%(2/50) of patients were taken up for LSCS foetal distress. 
94%  of patients were delivered with first dose of cerviprime gel induction. Of 
which  16% required oxytocin for acceleration.Both instrumental and 
caesarean section rate were same in both groups. 
  
 
 
 
 
 
Table 8 : Apgar score at 1” and 5” 
Cerviprime Gel group Oxytocin group Apgar score 
at No % No % 
1 minute 
6 / 10 
7 / 10 
8 / 10 
9 / 10 
 
2 
31 
17 
- 
 
4 
62 
34 
- 
 
4 
33 
13 
- 
 
8 
66 
26 
- 
‘p’ 0.4305  
Not significant  
5 minutes 
6 / 10 
7 / 10 
8 / 10 
9 / 10 
 
- 
2 
31 
17 
 
 
- 
4 
62 
34 
 
 
- 
3 
34 
13 
 
 
- 
6 
68 
26 
 
‘p’ 0.3534 
Not significant 
 
 Apgar score at 1 minute was 6/10 in 4%(2/50) of group A and 8%(4/50) 
of group B  babies. Apgar score at 1 minute was 7/10 in 62%(31/50) of group 
A and 66%(33/50) of group B babies. Apgar score at 1 minute was 8/10 in 
34%(17/50) of group A and 26%(13/50) of group B babies.   ‘p’ value was not 
significant in both groups. 
                Apgar score at 5 minutes was 7/10 in 4%(2/50) of group A and 
6%(3/50) of group B babies.Apgar score at 5minutes was 8/10 in 62% (31/50) 
of group A and 68%(34/50) of group B babies. Apgar score at 5 minutes 
was9/10 in 34% (17/50) of group A and 26%(13/50) of group B babies. ‘p’ 
value was not significant in both groups.  
 
 
 
 
Table 9 : Complications 
 
Cerviprime Gel 
group 
Oxytocin group Complications 
No % No % 
a) Intra Partum 
Fetal distress 
Nil 
 
6 
44 
 
12 
88 
 
4 
46 
 
8 
92 
‘p’ 0.7389 
Not significant 
b) Post partum 
PPH 
Nil 
 
2 
48 
 
4 
96 
 
3 
47 
 
6 
94 
‘p’ 0.5  
Not Significant 
 
   12% (6/50) of  patients in group A and 8%(4/50) of patients  in group 
B were developed foetal distress. None of the patients developed chorio 
amnionitis. None of the patients developed hyper stimulation.  
4%(2/50) of patients in group A and 6%(3/50)of patients in group B  
developed atonic PPH, which was managed medically.    
 
 
 
 
 
 
 
 Table 10 : Neonatal Outcome 
 
Cerviprime Gel group Oxytocin group Neonatal 
Outcome No % No % 
Admission HIE 1 5 10 5 10 
Admission MAS - - 3 6 
Not admitted 45 90 42 84 
Antibiotic 
received 
- - - - 
‘p’ 0.552 (Not Significant) 
 
 10%(5/50) of newborn in group A and 16%(8/50)of newborn in group B 
were admitted in neonatal intensive care unit were treated with antibiotics.  
90%(45/50) of newborn in group A and 84%(42/50) of newborn in 
group B had normal Apgar scores and didn’t require admission in neonatal 
intensive care unit. 
10% (5/50) in group A and 10% (5/50) in group B were admitted in 
neonatal intensive care unit for Hypoxic ischemic encephalopathy. 
 
 
 
 
 
 
 
 
 
 Table 11 : Stay in hospital 
 
Cerviprime Gel group Oxytocin group Stay in 
hospital (in 
days) 
No % No % 
3 days 40 80 41 82 
4 days 7 14 6 12 
More than 5 
days 
3 6 3 6 
Mean 3.44 3.36 
S.D 1.21 1.05 
‘p’ 0.8007  
Not Significant 
 
80% (40/50) of patients in group A and 82%(41/50) of patients in group 
B were discharged on 3rd day. 
14%(7/50) of patients in group A and 12% (3/50) of patients in group B 
were discharged on 4th day. 
6% (3/50) of patients in group A and 4%(2/50) of patients in group B 
were discharged on 8th day. 
 
 
 
 
DISCUSSION 
 Prelabour rupture of membranes is a common indication for 
induction of labour.  Clinical management of PROM at term remains 
controversial.  Many investigators believe that prolonged the interval 
from PROM to delivery is associated with increased incidence of 
maternal and perinatal infections. 
 Induction of labour with prostaglandins offers the advantage of 
promoting both cervical ripening and myometrial contractility in the 
group of women who present with premature rupture of membrane and 
an unfavourable cervix. 
 Common prostaglandins used are PGE1, PGE2. Misopostol is 
associated with more hyperstimulation and fetal distress.  PGE2 induces 
labour effectively in patients with unfavourable cervix. 
 Intravenous oxytocin in PROM with unfavorable cervix takes a 
longer time for induction to delivery.  In this study, of 100 patients for 
induction of labour in term PROM, 50 patients were given iv oxytocin 
infusion and 50 patients were given PGE2 cerviprime gel endocervically. 
1.  Age :   
 In our study, the mean age of the cases in cerviprime gel group was 
24.9 years and oxytoin group was 23.96 years.  In a study conducted by 
Chaudhuri Snehamay et al,  the mean age in cerviprime gel group was 
23.2 years and oxytocin group was 23.9 years. 
2.  Parity : 
In our study, 63% were primi gravidas, 37% were multigravidas. In the 
study conducted by Chaudhuri Snehamay et al,  75% were primi 
gravidas. The study conducted by Kodkany and Telang et al also had 
greater number of primigravidas. 
3.  Duration of PROM to induction : 
In our study, the duration of PROM to induction was between 2-4 hours 
in 54% of the cases in both groups.  This is in par  with the study 
conducted by Hauth et al which reported duration of PROM to induction 
was 3 hrs in 59%. 
4.  Bishop’s Score 
 In the study conducted by Chaudhuri Snehamay et al,   the Bishop’s 
score was < 6 in 67.5% of cases in cerviprime gel group and 69.6% in 
oxytocin group.  In our study, the Bishop’s score was < 6 in all patients in 
both groups. 
5.  Duration of PROM to delivery : 
The duration of PROM to delivery in gel group was 10 hrs for 
primi, 8.9 hrs for multi gravida, the mean was 9.5 hrs.  In oxytocin group 
PROM to delivery interval was 11.3 hrs in primi, 10.9 hrs in multi, mean 
was 11.1 hrs which was also statistically significant.  The mean latency 
between the PROM and delivery in the study conducted by Gonen et al, 
was 15 hr with PGE2 gel, Chaudhuri Snehamay et al, was 17 hrs.  In 
Gonen et al study, they have reported the duration of PROM to delivery 
to be 30 hrs, with the use of iv oxytocin for induction. But Chauduri 
Snehamay et al study, oxytocin was started after 12-24 hrs of PROM.  
The PROM to delivery interval was 21 hrs.  
6.  Induction to Delivery interval : 
 In cerviprime gel group, the mean time from induction to delivery 
was 7.1 hrs in primi, 5.9 hrs in multi with mean duration of 6.6 hrs.  In 
syntocinon group it was 8.4 hrs in primi, 7.9 hrs in multi, with mean 
duration of 8.2 hrs.  they were statistically significant. 
 The results were comparable with study conducting by Gonen et al 
(1992). The mean interval between the PG2 gel application and delivery 
was 6.6 hrs in their study.  Another study conducted by Chaudhuri 
Snehamay et al the mean duration of induction to delivery with PGE2 gel 
was 8.5 hrs. 
 In our study in the cerviprime gel group, 94%  delivered in a single 
application.  Of which, 16% required oxytocin for acceleration.  This was 
similar to the study conducted by Gonen et al, who reported that 93% 
delivered after a single application of PGE2 gel.  In Chaudhuri Snehamay 
et al study, they have reported 91.8% success rate.  Ben Haroush et al 
reported 80% success rate with induction by vaginal instruction of PGE2 
tablet. 
7.  Mode of Delivery : 
 The rate of cesarean section in our study was 6% for cerviprime gel 
group and 4% for oxytocin group.  A randomized control study 
conducted by Hannah et al they found there is no significant difference in 
the rate of ceasarean section. The study of induction with oxytocin or 
prostaglandin for planned management of PROM by Dare et al,  reported 
that there was no significant difference in the mode of delivery. 
8.  Apgar score : 
 Apgar score at 1 min was less than 7/10 in 4% of the cases in group 
A, compared to 8% in oxytocin group.  This is comparable with the study 
conducted by Chaudhury Snehamay et al, which reported the Apgar score 
at 1 minute to be less than 7 in 5.4% of cases in gel group Vs 7.1 % in 
oxytocin group. 
 None of the babies in either group had Apgar score less than 7/10 at 
5 minutes in our study and the study conducted by Chaudhury Snehamay 
et al.  Apgar score at 1 min and 5 min was not statistically significant in 
the Herabutya et al study. In our study also statistically significant 
difference was not noted in Apgar score at 1 min and 5 min. Also there 
was no significant difference in the incidence of fetal distress in both 
groups. 
9.   Perinatal outcome : 
 In Gonen et al study, there was no adverse perinatal outcome. The 
perinatal outcome was not significant in our study. 
10.  Maternal Complications : 
 Severe maternal complications like chorioamnionitis and post 
partum endometritis was not observed in both groups in our study.  
Chaudhury Snehamay et al, reported post partum fever in 1.8% of cases 
in gel group and 0.8% in oxytocin group. 
11. Duration of stay in hospital : 
 The duration of stay in hospital was not statistically significant in 
both groups. 
 
 
 
 
SUMMARY 
 This study evaluated the efficacy of PGE2 cerviprime gel for 
induction of labour in premature rupture of membranes with intravenous  
oxytocin. 
1. 58% of the patients in group A and 30% of the patients in group B 
belonged to age group of  25-29 years. 
2. 60% of the patients in group A and 66% of the patients in group B 
were primigravidas. 40% of the patients in Group A and 34% of the 
patients in Group B were multigravida. 
3. Premature rupture of membrane to induction in the interval was 2 
to 4 hrs in 54% of the cases in both groups. 
4. The Bishop’s score was less than 6 in all cases in both groups. 
5. The mean PROM to delivery interval was 9.5 hrs, with PGE2 gel, 
11.1  hrs with oxytocin which was statistically significant. (p = 
0.0002). 
6. The mean induction to delivery interval was 6.6 hrs with PGE2 gel, 
8.2 hrs with oxytocin which was statistically significant. 
(p=0.0001). 
6% of the cases in ceviprime gel group required a second gel after 6 
hrs of  induction and 16% of the cases in the same group required 
oxytocin for acceleration of labour. 
7. 94% in the gel group and 96% in oxytocin group delivered 
vaginally. 6% in the gel group and 4% in the oxytocin group 
delivered by caesarean section. 
8. 1 minute Apgar score was more than 7/10 in 96% of  cases  in 
group A and 92% of cases in group B.  5 minute Apgar score was 
more than 7/10 in all cases in both groups. 
9.  Fetal distress in gel group was 12% compared to 8% in oxytocin 
group. 
10. 4% of cases in gel group and 6% of cases in oxytocin group had 
post partum haemorrhage.  None of the patients developed 
chorioamnionitis or hyperstimulation in either groups. 
11. 10% of the babies in cerviprime gel group were admitted in NICU 
for hypoxic ischemic encephalopathy stage I.  10% of the babies in 
oxytocin group were admitted in NICU for hypoxic ischemic 
encephalopathy stage I and 6% for meconium aspiration syndrome 
12.   80% of the cases in both groups were discharged from hospital after  
 3 days. 
  
 
CONCLUSION 
 
1. Prostaglandin E2 gel was more effective and safer in 
induction of labour, in cases with premature rupture of 
membranes compared to intravenous oxytocin infusion. 
2. Use of PGE2 Gel for induction of labour in premature 
rupture of membrane significantly reduced the induction to 
delivery interval compared to intravenous oxytocin. 
3. There was no significant difference in the mode of delivery 
between both groups. 
4. There was no significant difference in the neonatal outcome 
and immediate puerperal problems between both groups. 
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PROFORMA 
1. Name: 
2. Age   : 
3. IP no : 
4. Obstetric code: 
5. Gestational age:                   LMP:           EDD: 
6. Ultrasound: 
7. Date and time of admission:       
8. Date and time of rupture of membranes: 
9. Method of confirming rupture of membranes: 
  A) Pooling of liquor on speculum examination                              
B) Absent membranes                                 
  C) Reduced liquor on USG 
10. Bishop’s score: 
11. Date and time of induction : 
12. Method of induction : 
         a) PGE2 gel                     b)oxytocin         
 Repeat  gel 
 Oxytocin for augmentation 
13. Date and time of delivery : 
14. Mode of delivery : 
o labour naturale 
o operative vaginal 
o caesarean 
15. Duration of PROM : 
16. Duration of induction to delivery : 
17. Duration of PROM to delivery : 
18. Intrapartum complications:  
            i)   Hyperstimulation 
            ii)   Foetal distress 
           iii)  Chorioamnionitis 
           iv)  PPH 
19. Neonatal outcome 
          1. Apgar    1minute 
                          5minutes 
         2. Resuscitation with oxygen 
         3. Admission in NICU 
         4. Neonatal infection 
         5. Neonatal death 
20. Duration of stay in hospital 
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1 31283 GEL 23 1 38 C 3 420 660 240 No No - 7 8 - - 3 
2 31207 GEL 29 2 37 C 4 360 740 380 No No - 8 9 - - 3 
3  33508 GEL 23 1 38 C 4 285 685 400 No No - 7 8 - - 3 
4  31297 GEL 27 1 38 C 5 310 570 260 No No - 8 9 - - 3 
5  33021 GEL 27 2 38 C 4 120 520 400 No No - 8 9 - - 3 
6  33824 GEL 24 1 37 C 3 80 540 460 No No - 8 9 - - 3 
7  46611 GEL 21 2 38 C 3 135 675 540 No YES Fetal Distress 7 8 Admission HIE I - 8 
8  475190 GEL 20 1 38 C 3 180 525 345 No No - 7 8 - - 3 
9  48199 GEL 28 2 38 C 4 110 570 460 No No - 7 8 - - 3 
10  42744 GEL 26 2 38 C 3 150 485 335 No No - 8 9 - - 3 
11  46599 GEL 21 1 37 C 4 150 615 465 No No - 8 9 - - 3 
12  44548 GEL 29 2 38 C 3 180 630 450 No No - 7 8 - - 4 
13  43546 GEL 21 2 38 C 5 90 375 285 No No - 8 9 - - 3 
14  42590 GEL 26 1 37 C 3 150 695 545 No No - 7 8 - - 3 
15  45133 GEL 26 1 37 C 3 210 885 675 No YES Fetal Distress 6 8 Admission HIE I - 8 
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16  44536 GEL 29 1 37 C 4 120 490 370 No No - 8 9 - - 3 
17  48205 GEL 22 1 38 C 4 210 750 540 YES No - 7 8 - - 4 
18  48470 GEL 26 2 38 C 3 105 490 385 No No - 7 8 - - 3 
19  44810 GEL 20 1 37 C 4 210 685 475 No No - 8 9 - - 3 
20  46290 GEL 26 1 37 C 4 210 690 480 No No - 7 8 - - 3 
21  48640 GEL 22 1 38 C 3 120 665 545 No No - 7 8 - - 3 
22  48592 GEL 20 1 38 C 3 89 460 371 No No - 7 8 - - 3 
23  54210 GEL 22 2 37 C 3 170 485 315 No No - 8 9 - - 3 
24  48581 GEL 24 1 38 C 4 140 645 505 No No - 7 8 - - 3 
25  48153 GEL 24 2 38 C 5 150 465 315 No No - 7 8 - PPH 3 
26  48205 GEL 22 1 38 C 5 70 520 450 No No - 7 8 - - 3 
27  52942 GEL 27 2 38 C 4 120 510 390 No No - 8 9 - - 3 
28  53508 GEL 22 1 37 C 4 210 720 510 YES No Fetal Distress 6 8 - - 4 
29  51524 GEL 22 1 38 C 3 185 640 455 No No - 7 8 - - 3 
30  51070 GEL 26 1 37 C 3 75 490 415 No No - 7 8 - - 3 
31  51084 GEL 26 1 38 C 3 210 620 410 No YES - 7 8 - - 4 
32  50725 GEL 26 1 37 C 4 185 610 425 No YES - 7 8 - - 3 
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33  50804 GEL 27 2 37 C 3 180 680 500 No YES Fetal Distress 7 7 Admission HIE I - 4 
34  53504 GEL 22 2 38 C 3 210 660 450 No YES - 7 8 - - 3 
35  51334 GEL 26 1 38 C 4 135 520 385 No No - 7 8 - - 3 
36  53818 GEL 28 2 38 C 4 60 385 325 No No - 8 9 - - 3 
37  55842 GEL 28 2 38 C 4 95 405 310 No No - 7 8 - PPH 3 
38  55333 GEL 26 1 37 C 3 160 835 675 YES No Fetal Distress 7 7 Admission HIE I - 8 
39  52017 GEL 26 1 38 C 4 110 665 555 No YES - 7 8 - - 3 
40  55345 GEL 25 1 38 C 5 210 610 400 No No - 8 9 - - 3 
41  54410 GEL 21 1 38 C 3 185 410 225 No No - 8 9 - - 3 
42  54390 GEL 26 2 39 C 4 240 400 160 No No - 8 9 - - 3 
43  55342 GEL 28 2 38 C 5 195 465 270 No No - 7 8 - - 3 
44  59669 GEL 25 1 38 C 3 150 390 240 No No - 7 8 - - 3 
45  60180 GEL 25 1 38 C 3 90 470 380 No No - 7 8 - - 4 
46  61240 GEL 22 1 38 C 3 120 560 440 No No Fetal Distress 7 8 Admission HIE I - 4 
47  62797 GEL 28 2 38 C 3 360 765 405 No YES - 8 9 - - 3 
48  61263 GEL 28 1 38 C 3 175 448 273 No No - 7 8 - - 3 
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49  61280 GEL 30 2 37 C 4 310 470 160 No No - 7 8 - - 3 
50  62780 GEL 27 2 37 C 3 295 615 320 No No - 8 9 - - 3 
51  42575 SYN 22 1 38 C 4 110 630 520 - - - 8 9 - - 3 
52  44606 SYN 22 1 37 C 4 140 680 540 - - Fetal Distress 7 8 Admission MAS - 4 
53  43787 SYN 23 1 38 C 3 160 670 510 - - - 7 8 - - 3 
54  43517 SYN 20 2 37 C 5 120 590 470 - - - 7 8 - - 3 
55  44584 SYN 23 2 37 C 4 300 695 395 - - - 7 8 - - 3 
56  47907 SYN 29 1 38 C 4 180 675 495 - - - 7 8 - - 3 
57  41576 SYN 30 2 37 C 5 35 525 490 - - - 8 9 - - 3 
58  48508 SYN 19 1 38 C 4 180 655 475 - - - 7 8 Admission HIEI - 4 
59  48850 SYN 20 1 37 C 4 150 675 525 - - - 7 8 - - 3 
60  47029 SYN 19 2 38 C 5 150 575 425 - - - 8 9 - - 3 
61  48818 SYN 30 2 38 C 4 160 595 435 - - - 8 9 - - 3 
62  48518 SYN 24 1 39 C 4 100 790 690 - - - 7 8 - PPH 4 
63  48586 SYN 20 1 38 C 4 150 735 585 - - Fetal Distress 6 8 Admission MAS - 4 
64  49501 SYN 29 2 37 C 3 80 600 520 - - - 8 9 - - 3 
65  49769 SYN 20 1 38 C 4 160 630 470 - - - 7 8 Admission HIE I - 4 
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66  50145 SYN 29 1 37 C 4 260 710 450 - - - 8 9 - - 3 
67  50183 SYN 24 2 37 C 5 150 620 470 - - - 8 9 - - 3 
68  54995 SYN 28 2 37 C 4 360 810 450 - - - 7 8 - - 3 
69  50550 SYN 22 1 38 C 4 330 925 595 - - - 7 8 - - 3 
70  50223 SYN 23 2 38 C 4 120 580 460 - - - 7 8 - - 3 
71  50577 SYN 22 1 38 C 4 190 670 480 - - - 8 9 - - 3 
72  50710 SYN 23 1 38 C 4 150 645 495 - - - 7 8 - - 3 
73  51356 SYN 29 1 38 C 3 120 665 545 - - - 7 8 - - 3 
74  50297 SYN 23 1 39 C 5 180 720 540 - - - 7 8 - - 3 
75  50245 SYN 24 2 38 C 5 140 555 415 - - - 7 8 - - 3 
76  52670 SYN 29 1 38 C 4 255 650 395 - - Fetal Distress 6 7 Admission MAS - 8 
77  50518 SYN 29 1 39 C 4 70 550 480 - - - 8 9 - - 3 
78  50539 SYN 19 1 37 C 4 190 630 440 - - - 8 9 - - 3 
79  51829 SYN 18 1 38 C 5 150 600 450 - - - 7 8 - - 3 
80  52061 SYN 23 1 37 C 4 225 685 460 - - - 7 8 - - 4 
81  52278 SYN 23 2 37 C 4 300 840 540 - - - 7 8 - - 3 
82  52078 SYN 29 1 39 C 4 210 590 380 - - - 8 9 - - 3 
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83  52386 SYN 23 2 38 C 4 280 700 420 - - - 7 8 - - 3 
84  52084 SYN 21 1 38 C 3 210 655 445 - - - 7 7 Admission HIE I PPH 5 
85  52284 SYN 23 1 38 C 4 170 635 465 - - Fetal Distress 6 7 Admission HIE  I - 8 
86  53256 SYN 25 1 38 C 3 135 645 510 - - - 7 8 - - 3 
87  53497 SYN 22 1 38 C 4 180 780 600 - - - 7 8 - - 3 
88  53290 SYN 22 2 38 C 3 180 810 630 - - - 8 9 - - 3 
89  53225 SYN 21 1 38 C 4 275 650 375 - - - 7 8 - - 3 
90  53540 SYN 28 2 38 C 3 150 780 630 - - - 7 8 - - 3 
91  53844 SYN 29 1 38 C 3 210 615 405 - - - 8 9 Admission HIE I - 3 
92  53523 SYN 29 2 38 C 4 50 530 480 - - - 7 8 - - 3 
93  54210 SYN 22 1 38 C 4 110 615 505 - - - 7 8 - - 3 
94  55951 SYN 28 2 37 C 4 255 675 420 - - - 7 8 - - 3 
95  54360 SYN 25 1 38 C 3 30 600 570 - - - 7 8 - - 3 
96  54332 SYN 22 1 38 C 4 270 810 540 - - - 7 8 - - 3 
97  53970 SYN 23 1 37 C 3 330 1000 670 - - - 6 8 - PPH 3 
98  54436 SYN 21 1 38 C 4 140 675 535 - - - 7 8 - - 3 
99  54890 SYN 21 1 38 C 4 50 660 610 - - - 7 8 - - 3 
100  54321 SYN 26 2 38 C 4 215 655 440  - - - 7 8 - - 3 
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